NU Skin Enterprises (NUS) Q3 FY2026 earnings: revenue $311 million, down 14.6% on the year

NU Skin Enterprises, Inc. (NUS) reported revenue of $311 million for Q3 FY2026, the quarter ended 30 September 2026, down 14.6% on the same quarter a year earlier. Net income was -$742,000, and diluted earnings per share $-0.02. The figures are the company's own, from the 10-Q it filed with the SEC on 6 November 2026.

Revenue

$311 million

-14.6% on the year · -2.8% on the quarter

Q4 FY2024Q3 FY2026

Operating margin

1.6%

5.9% a year earlier

Q4 FY2024Q3 FY2026

Net income

-$742,000

Q4 FY2024Q3 FY2026

Diluted EPS

-$0.02

Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 2 lowered, 3 new, 1 kept.

Revenue fell 14.6% year on year: Revenue was $311.0 million against $364.2 million, down 14.6%; constant-currency change was (13.5)% and FX reduced revenue by $3.9 million. Nine-month revenue was $951.7 million, down 14.6%.
Diluted EPS was $(0.02): Diluted EPS was $(0.02) against $0.34, or $0.10 excluding certain charges. The company reported a net loss of $0.7 million, against net income of $17.1 million a year earlier.
Nu Skin business revenue down 19.2%: Total Nu Skin revenue was $252.6 million against $312.6 million, down 19.2% (18.0% at constant currency). Nine-month Nu Skin revenue was $795.7 million, down 15.3%.

Read the earnings call summary

Income statement (profit and loss)

$ million	Q3 FY2026	Q2 FY2026	Q3 FY2025	On the quarter	On the year
Revenue	311	320	364	-2.8%	-14.6%
Cost of revenue	109	102	107	+6.9%	+1.3%
Gross profit	202	218	257	-7.4%	-21.3%
Gross margin	65.0%	68.2%	70.5%
Operating income	5.1	-59.3	21.6		-76.5%
Operating margin	1.6%	-18.5%	5.9%
Interest expense	3.5	3.3	4.1	+5.3%	-15.6%
Pre-tax income	1.9	-63.2	16.0		-88.2%
Income tax	2.6	187	-1.1	-98.6%
Effective tax rate	139.3%	n/a	-6.8%
Net income	-0.7	-250	17.1
Net margin	-0.2%	-78.0%	4.7%
Diluted EPS	-$0.02	-$5.14	$0.34

$ million except per share.

Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ million	Q3 FY2026	Q2 FY2026	Q3 FY2025	On the quarter	On the year
Operating cash flow	-8.1	10.6	27.5
Capital expenditure	11.3	5.6	9.9	+101.3%	+14.5%
Free cash flow	-19.5	5.0	17.6
Free cash flow margin	-6.3%	1.6%	4.8%
Cash from investing	-5.1	-5.6	-9.9
Cash from financing	-13.5	-13.4	-26.9
Depreciation and amortisation	12.5	12.7	12.1	-1.0%	+3.7%
Share-based compensation	2.7	1.1	5.8	+142.5%	-53.4%
Buybacks	0.0	0.0	5.0
Dividends paid	2.9	2.9	3.0	+0.5%	-1.1%
Diluted shares, weighted	49m	49m	50m	+0.2%	-3.2%
Shares outstanding at period end	49m	49m	49m	+0.0%	-0.1%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ million	Q3 FY2026	Q2 FY2026	Q3 FY2025	On the quarter	On the year
Shareholders' equity	547	543	800	+0.9%	-31.5%
Debt	204	214	229	-4.6%	-11.1%
Operating lease liabilities	48.7	50.1	62.4	-2.8%	-22.0%
Other liabilities	288	315	333	-8.5%	-13.5%
Total liabilities and equity	1,088	1,122	1,424	-3.0%	-23.6%
Fixed assets	383	380	375	+0.9%	+2.0%
Goodwill	4.8	4.8	83.6	0.0%	-94.3%
Intangible assets	36.4	37.9	44.2	-4.0%	-17.7%
Investments	1.7	1.7	1.2	-0.4%	+43.5%
Cash and equivalents	165	190	252	-13.0%	-34.5%
Receivables	51.4	48.9	48.9	+5.1%	+5.1%
Inventory	192	191	179	+0.1%	+7.4%
Other assets	254	268	441	-5.0%	-42.3%
Total assets	1,088	1,122	1,424	-3.0%	-23.6%

Questions

What was NU Skin Enterprises' revenue in Q3 FY2026?

NU Skin Enterprises (NUS) reported revenue of $311 million for Q3 FY2026, the quarter ended 30 September 2026, down 14.6% on the same quarter a year earlier.

How much did NU Skin Enterprises earn in Q3 FY2026?

Net loss for Q3 FY2026 was $742,000, and the diluted loss per share $0.02.

When did NU Skin Enterprises report Q3 FY2026 results?

NU Skin Enterprises filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 6 November 2026.

Quarterly results, the last 20 quarters

	Q4 FY2021 *	Q1 FY2022	Q2 FY2022	Q3 FY2022	Q4 FY2022 *	Q1 FY2023	Q2 FY2023	Q3 FY2023	Q4 FY2023 *	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026	Q3 FY2026
Revenue	673	605	561	538	522	481	500	499	489	417	439	430	446	364	386	364	370	321	320	311
Cost of revenue	174	161	148	174	148	134	136	207	136	123	132	129	166	118	120	107	108	106	102	109
Gross profit	500	443	413	364	375	348	365	292	352	294	307	301	279	247	266	257	262	214	218	202
Gross margin	74%	73%	74%	68%	72%	72%	73%	59%	72%	70%	70%	70%	63%	68%	69%	70%	71%	67%	68%	65%
Operating income	20.3	52.1	51.5	-20.3	27.5	16.1	42.5	-26.4	16.1	8.8	-126	18.2	-53.1	-9.9	30.8	21.6	23.2	4.0	-59.3	5.1
Operating margin	3%	9%	9%	-4%	5%	3%	8%	-5%	3%	2%	-29%	4%	-12%	-3%	8%	6%	6%	1%	-19%	2%
Interest expense	n/a	n/a	n/a	n/a	n/a	4.9	5.8	7.5	7.4	7.3	6.7	6.5	5.9	3.3	2.5	4.1	4.0	4.2	3.3	3.5
Pre-tax income	18.4	50.7	42.9	-29.0	24.4	14.6	37.1	-34.5	9.3	1.1	-132	13.3	-57.8	135	27.4	16.0	18.2	2.6	-63.2	1.9
Tax rate	150%	24%	20%	n/a	-135%	22%	28%	n/a	22%	148%	n/a	38%	n/a	20%	23%	-7%	20%	29%	n/a	139%
Net income	-9.2	38.7	34.2	-25.4	57.2	11.4	26.9	-37.0	7.3	-0.5	-118	8.3	-36.1	108	21.1	17.1	14.5	1.8	-250	-0.7
Net margin	-1%	6%	6%	-5%	11%	2%	5%	-7%	1%	-0%	-27%	2%	-8%	29%	5%	5%	4%	1%	-78%	-0%
Diluted EPS	-$0.17	$0.76	$0.67	-$0.51	$1.15	$0.23	$0.54	-$0.74	$0.15	-$0.01	-$2.38	$0.17	-$0.73	$2.14	$0.43	$0.34	$0.29	$0.04	-$5.14	-$0.02
Operating cash flow	110	7.5	46.6	28.4	25.5	-22.1	35.5	51.0	54.2	3.3	51.2	31.4	25.8	0.4	35.8	27.5	16.6	-3.9	10.6	-8.1
Capital expenditure	18.2	10.3	9.5	25.5	13.8	11.5	14.7	11.9	20.4	12.3	8.1	8.6	12.6	13.6	0.0	9.9	10.8	13.7	5.6	11.3
Free cash flow	91.3	-2.7	37.0	3.0	11.7	-33.6	20.8	39.1	33.8	-9.0	43.1	22.8	13.2	-13.2	35.8	17.6	5.9	-17.6	5.0	-19.5
Buybacks	10.0	10.0	10.0	40.0	10.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	5.0	10.0	5.0	0.0	0.0
Dividends paid	18.9	19.3	19.4	19.3	19.0	19.4	19.5	19.5	19.3	3.0	3.0	3.0	3.0	3.0	3.0	3.0	2.9	2.9	2.9	2.9
Shares outstanding	50m	50m	50m	49m	49m	50m	50m	49m	49m	50m	50m	50m	50m	49m	49m	49m	48m	49m	49m	49m
Filing	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2026, filed 6 November 2026: the filing.